|
Type 2 diabetes
Citations 261-270 of 449 total displayed.
|
Past content
(since Jan 2001):
|
- Coronary Heart Disease
Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy
- Dick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, William F. Keane, Zhongxin Zhang, Shahnaz Shahinfar, Steve Snapinn, Mark E. Cooper, William E. Mitch, and Barry M. Brenner
Circulation 2004;110:921-927; published online before print as doi:10.1161/01.CIR.0000139860.33974.28
[Abstract]
[Full text]
- Articles
National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study
- Kelly J. Hunt, Roy G. Resendez, Ken Williams, Steve M. Haffner, and Michael P. Stern
Circulation published August 23, 2004, doi:10.1161/01.CIR.0000140762.04598.F9
[Abstract]
- Articles
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
- Shaista Malik, Nathan D. Wong, Stanley S. Franklin, Tripthi V. Kamath, Gilbert J. L’Italien, Jose R. Pio, and G. Rhys Williams
Circulation published August 23, 2004, doi:10.1161/01.CIR.0000140677.20606.0E
[Abstract]
- Articles
Leptin Induces Hypertrophy via Endothelin-1-Reactive Oxygen Species Pathway in Cultured Neonatal Rat Cardiomyocytes
- Fang-Ping Xu, Min-Sheng Chen, Yan-Zhen Wang, Quan Yi, Shu-Bing Lin, Alex F. Chen, and Jian-Dong Luo
Circulation published August 16, 2004, doi:10.1161/01.CIR.0000140766.52771.6D
[Abstract]
- Articles
Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy
- Dick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, William F. Keane, Zhongxin Zhang, Shahnaz Shahinfar, Steve Snapinn, Mark E. Cooper, William E. Mitch, and Barry M. Brenner
Circulation published August 9, 2004, doi:10.1161/01.CIR.0000139860.33974.28
[Abstract]
- Correspondence
Metabolic Syndrome: A Definition in Progress • Response
- Hoong Sern Lim, Jeetesh V. Patel, Gregory Y.H. Lip, and Scott M. Grundy
Circulation 2004;110:e35, doi:10.1161/01.CIR.0000139383.19636.D6
[Full text]
- Coronary Heart Disease
High Levels of Dietary Advanced Glycation End Products Transform Low-Density Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients
- Weijing Cai, John Cijiang He, Li Zhu, Melpomeni Peppa, Changyong Lu, Jaime Uribarri, and Helen Vlassara
Circulation 2004;110:285-291; published online before print as doi:10.1161/01.CIR.0000135587.92455.0D
[Abstract]
[Full text]
- Vascular Biology
Regression of Carotid Atherosclerosis by Control of Postprandial Hyperglycemia in Type 2 Diabetes Mellitus
- Katherine Esposito, Dario Giugliano, Francesco Nappo, Raffaele Marfella for the Campanian Postprandial Hyperglycemia Study Group
Circulation 2004;110:214-219; published online before print as doi:10.1161/01.CIR.0000134501.57864.66
[Abstract]
[Full text]
- Original Articles
High Levels of Dietary Advanced Glycation End Products Transform Low-Dersity Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients
- Weijing Cai, John Cijiang He, Li Zhu, Melpomeni Peppa, Changyong Lu, Jaime Uribarri, and Helen Vlassara
Circulation published July 12, 2004, doi:10.1161/01.CIR.0000135587.92455.0D
[Abstract]
- Editorials
Protein Kinase Cß Isoform Inhibitors: A New Treatment for Diabetic Cardiovascular Diseases
- Zhiheng He and George L. King
Circulation 2004;110:7-9, doi:10.1161/01.CIR.0000133428.02295.6C
[Full text]
|
|
